ClinicalTrials.gg
Drug

Iron isomaltoside 1000 clinical trials

Also written Monofer, Ferric derisomaltose and Monoferric.

studies test it
80
open now
29
in phase 3
33
first study started
2007

How each study uses iron isomaltoside 1000 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the iron isomaltoside 1000 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Iron Isomaltoside 1000
19
Iron isomaltoside
11
Iron isomaltoside/ferric derisomaltose
5
Monofer®, Monoferric®, Monover®, Monofar®, Monoferro®
5
iron isomaltoside 1000 (Monofer®)
4

Brand

Monofer
32
Monoferric
6

Other names

Ferric derisomaltose
19

Studies by the year they started

79 studies that test it; most in 2023 (11)

Studies that test iron isomaltoside 1000, by start year
YearStudies
20072
20091
20102
20113
20126
20134
20141
20151
20166
20178
20184
20193
20204
20214
20225
202311
20242
20258
20264

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
6
Phase 2
7
Phase 3
33
Phase 4
25
No phase
9

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 30 · Other 50

Pharmacosmos A/S (29) · Yonsei University (6) · China-Japan Friendship Hospital (4) · Oslo University Hospital (2) · Massachusetts General Hospital (1) · Brigham and Women's Hospital (1) · Thomas Jefferson University (1) · Michael Kremke (1)

Often tested with

Tested in the same studies.

Ferric carboxymaltose (3) · Iron sucrose (3) · Iron (1) · Ferrous fumarate (1) · Tranexamic Acid (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 12, 4 in phase 3

Studies that test iron isomaltoside 1000, phase 3 first.

Studies

Open first, then newest update. How each study uses iron isomaltoside 1000 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 80

See all 80 studies that test iron isomaltoside 1000 →

As the comparator · 1 — what is tested is compared with iron isomaltoside 1000

Codes

What other systems call iron isomaltoside 1000 · ClinicalTrials.gg INT005816

  • MeSH (NLM) C557707iron isomaltoside 1000Confirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 3M6325NY1RIRON ISOMALTOSIDE 1000Confirmed FDA, NLM, Wikidata
  • Wikidata Q112131611iron isomaltoside 1000Confirmed FDA, NLM, Wikidata
  • NCI Thesaurus C92584Iron Isomaltoside 1000Confirmed FDA, Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.